Glycopeptide-Intermediate Staphylococcus aureus: Evaluation of a Novel Screening Method and Results of a Survey of Selected U.S. Hospitals

Isolates of Staphylococcus aureus with decreased susceptibilities to glycopeptide antimicrobial agents, such as vancomycin and teicoplanin, have emerged in the United States and elsewhere. Commercially prepared brain heart infusion agar (BHIA) supplemented with 6 μg of vancomycin per ml was shown in...

Полное описание

Библиографические подробности

Опубликовано в::	J Clin Microbiol
Главные авторы:	Hubert, Susannah K., Mohammed, Jasmine M., Fridkin, Scott K., Gaynes, Robert P., McGowan, John E., Tenover, Fred C.
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1999
Предметы:	Bacteriology
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC85700/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10523558/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.37.11.3590-3593.1999
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!